Lv31
380 积分 2021-05-30 加入
Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?
7小时前
已完结
Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies
7小时前
已完结
Brighter days ahead: the shifting landscape of IBD therapy
7小时前
已完结
TL1A as a therapeutic target in inflammatory bowel disease
7小时前
已完结
New Kids on the Block: IL-23 Inhibitors in IBD Management
7小时前
已完结
Targeting IL-23 for IBD: Rationale and Progress to Date
7小时前
已完结
Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease
7小时前
已完结
Advanced therapies targeting IL-23: clinical outcomes in ulcerative colitis
7小时前
已完结
Review Article: TL1A Inhibitors in IBD ‐ Mechanistic Rationale and Clinical Evidence
7小时前
已完结
The TL1A inhibitors in IBD: what’s in the pot?
7小时前
已完结
皖公网安备34019202002308
